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Abstract 
We have demonstrated that the endothelial cell-derived superoxide anion is deeply involved in the endothelial cell injury induced by 
activated neutrophils (Fujita, H., Morita, 1. and Murota, S. (1994) Arch. Biochem. Biophys. 309, 62-69). To clarify the mechanism 
underlying the increase in the endothelial cell-derived superoxide anion induced by activated neutrophils, the conversion of xanthine 
dehydrogenase (XD) to xanthine oxidase (X0) in cultured endothelial cells isolated from bovine carotid arteries was investigated. 
Although the endothelial cells expressed both XD and X0 activity, the X0 activity of unstimulated cells comprised about 12% of the total 
(XD + X0) activity. When endothelial cells were exposed to neutrophils activated with phorbol 12-myristate 13-acetate (PM& X0 
activity rapidly increased about 3-fold over the control. Whereas treatment of endothelial cells with PMA alone or unstimulated 
neutrophils alone did not increase the X0 activity at all. The increase in X0 activity in endothelial cells was also observed on the 
treatment of the cells with neutrophils activated with leukotriene B, or thrombin. To determine whether or not proteases released from 
activated neutrophils are involved in the increased conversion of XD to X0 in endothelial cells, the effects of the elastase specific 
inhibitor, ONO-5046, and protease inhibitors, such as aprotinin, gabexate mesylate and urinastatin, were examined. However, these 
protease inhibitors did not suppress the conversion of XD to X0 induced by PMA-activated neutrophils. Moreover, the treatment of 
endothelial cells with purifilad human neutrophil elastase and H,O, also did not affect the conversion at all. In contrast, monoclonal 
antibodies against CDlla and CD18 significantly inhibited the increased conversion of XD to X0 induced by PMA-activated neutrophils. 
Moreover, tyrosine kinase inhibitors such as staurosporine and herbimysine also inhibited the increased conversion of XD to X0 induced 
by PM&activated neutrophils. These results indicate that the adhesion of activated neutrophils to endothelial cells via CDlla/CD18- 
ICAM- is involved in the conversion of XD to X0 in endothelial cells induced by activated neutrophils. 
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1. Introduction 
Neutrophils play a critical role in inflammatory diseases 
[l-4]. Several studies have demonstrated that endothelial 
cell injury caused by activated leukocytes is the initial 
stage of these diseases’ processes [5]. The endothelial cell 
injury is caused by active oxygen species released from 
activated leukocytes such as the superoxide anion (O;), 
hydrogen peroxide, and hydroxyl radicals [6,7]. Recently, 
the phenomenon of the adhesion of leukocytes to the 
endothelium has been recognized as an important process 
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in endothelial cell injury caused by leukocytes [S]. The 
adhesion of leukocytes to the endothelium is mediated by 
various kinds of adhesion molecules, such as very late 
antigen-4 (VLA-4) and vascular cell adhesion molecule-l 
(VCAM-l), CDlla/CD18 and intercellular adhesion 
molecule-l,-2 (ICAM-l,-2), and CDllb/CD18 and 
ICAM-1, and so on [9-111. In the previous paper, we 
reported that the adhesion of leukocytes to the endothelium 
via the binding of CDll/CDlS and ICAM- is involved 
in the endothelial cell injury elicited by phorbol lZmyri- 
state 13-acetate (PIHA)-activated neutrophils [12]. We also 
demonstrated that the endothelial cell-derived 0; con- 
tributes to the endothelial cell injury induced by activated 
neutrophils [ 131. Moreover, several studies have revealed 
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that xanthine oxidase inhibitors such as allopurinol and 
oxypurinol had a protective effect against activated leuko- 
cyte-mediated endothelial cell injury [14], suggesting that 
intracellular xanthine oxidase (X0), which converts 0, to 
0; [15] in the presence of xanthine, plays an important 
role in endothelial cell injury elicited by activated leuko- 
cytes. In most tissues, X0 is usually present in the 
dehydrogenase form, xanthine dehydrogenase (XD), which 
uses NAD+ (nicotinamide adenine dinucleotide) instead of 
0, as the electron acceptor [16]. It is commonly recog- 
nized that the conversion of XD to X0 is an important 
process for the production of 0, under some pathological 
conditions. These facts indicate the possibility that acti- 
vated neutrophils stimulate conversion of XD to X0 in 
endothelial cells. The purpose of the studies described in 
this paper is to show that the adhesion of neutrophils to 
endothelial cells through CDlla/CDl&ICAM-1 is in- 
volved in the conversion of XD to X0. Moreover, we will 
demonstrate that activation of tyrosine kinase may con- 
tribute to the conversion of XD to X0 via the binding of 
CDlla/CD18-ICAM-1. 
2. Materials and methods 
2.1. Reagents 
Phenylmethylsulfonylfluoride (PMSF), dithiothreitol 
(DTE), pyruvate, NAD+, -phorbol 1Zmyristate 13-acetate 
(PMA), thrombin, leukotriene B, (LTB,), and human neu- 
trophil elastase were purchased from Sigma (St. Louis, 
MO, USA). Uric acid, lactate dehydrogenase (LDH), 
EDTA, and aprotinin were obtained from Wako Pure 
Chemical Industries (Osaka, Japan). Xanthine was pur- 
chased from ICN Biochemicals (Cleveland, OH, USA). 
Anti-CDlla (clone 25.3.1) was obtained from Cosmo Bio 
(Tokyo, Japan). Anti-CD18 (clone P4H9) was obtained 
from Life Technologies Oriental (Tokyo, Japan). Gabexate 
mesylate and ONO-5046 were generous gifts from Ono 
Pharmaceutical (Osaka, Japan). Urinastatin was a generous 
gift from Mochida Pharmaceutical (Tokyo, Japan). 
2.2. Endothelial cell culture 
Endothelial cells were isolated from bovine carotid 
arteries as previously described [17]. They were main- 
tained and subcultured as monolayers in an Eagle’s mini- 
mal essential medium (Life Technologies Oriental, Tokyo, 
Japan) containing 10% fetal bovine serum. Experiments 
were performed with these cells under 10 passages. For 
enzyme assays, cells were plated onto 35 mm dishes and 
allowed to grow to confluence. 
2.3. Isolation of neutrophils 
Human neutrophils were isolated from peripheral blood 
by dextran sedimentation, followed by density gradient 
centrifugation with Lymphoprep (Nycomed, Norway) and 
hypotonic lysis. The cells were finally suspended in a 
Hanks’ balanced salt solution (HBSS) and kept on ice until 
use. 
2.4. Enzyme assays 
Xanthine oxidase and xanthine dehydrogenase activities 
were assayed as described [18]. Endothelial cell monolay- 
ers were washed twice with a HBSS. The buffer alone or 
together with neutrophils (4.7 . lo6 cells/well) was then 
added to the monolayers. The wells were kept at 37°C in a 
CO, incubator for 15 min, and then treated with PMA 
(final concentration, 10 ng/ml) for 30 min, except for in 
the time-course studies, as indicated in the figure legends. 
When indicated, monoclonal antibodies, the control anti- 
body or elastase inhibitors were added before the addition 
of neutrophils. After incubation, the medium was removed, 
and the wells were washed twice with a KPO,-buffered 
saline (10 mM, pH 7.4). After being mechanically har- 
vested with a rubber policeman in 1 ml of ice-cold KPO, 
(50 mM, pH 7.8) containing EDTA (1 mM), DTE (1 mM), 
and PMSF (1 mM), the cells were immediately homoge- 
nized with a homogenizer at 100 watts for 1 min on ice. 
The homogenate was centrifuged at 25 000 X g for 15 min 
at 4°C. The supernatant (400 ~1) of each sample was 
incubated at 37°C for 3 h with xanthine (100 PM) to 
measure xanthine oxidase, or with xanthine plus NAD+ 
(300 PM), LDH (70 U), and pyruvate (1.75 mM) to 
measure xanthine oxidase plus xanthine dehydrogenase. 
The reactions were stopped by the addition of perchloric 
acid and the precipitate was removed by centrifugation. 
The samples stored frozen in tightly capped vials at - 80°C 
for storage until analysis, usually within 48 h, by HPLC. 
This period of storage did not cause any artifactual alter- 
ation in the amount of detectable uric acid product. Uric 
acid was quantified by high-pressure liquid chromatog- 
raphy on a Shimadzu C-18 reverse phase column 
(Shimadzu, Osaka, Japan) with a mobile phase of 20 
KH,PO,, pH 5.7, plus methanol (3%) at 1 ml/min. 
peak of uric acid was detected at 290 nm. 
2.5. Statistical analysis 
mM 
The 
Data were analyzed by one-way analysis of variance 
(ANOVA), followed by Dunn’s test. 
3. Results 
3.1. Activated neutrophils induce conversion of XD to X0 
At first, we examined the effect of activated neutrophils 
on the conversion of XD to X0 in endothelial cells 
isolated from bovine carotid arteries. The experiment (n = 
4) was repeated 4 times under the same conditions, and 
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Fig. 1. PMA-activated neutrophils induce conversion of XD to X0 in 
bovine carotid artery endothelial cells. HBSS alone or together with 
neutrophils (4.7.106 cells/well) was added to bovine carotid artery 
endothelial cell monolayers, followed by treatment with phorbol 12-myri- 
state 13-acetate (PMA, final concentration, 10 ng/ml). After 30 min, the 
cells were harvested and assayed for the contents of XD and X0, as 
described under Section 2. X0 activity is expressed as a percentage of the 
total XD and X0 activity. All (data are presented as mean+S.E., with 
n = 4. All data are representative of 4 times of individual experiments. 
CONT: no addition, PMA: addition of PMA, PMN: addition of neu- 
trophils, PMA + PMN: addition of PMA-activated neutrophils. * * P < 
0.01: significant difference from CONT. 
similar result was obtained each time. As shown in Fig. 1, 
the basal level of X0 in the endothelial cells comprised 
about 12% of the total activity of XD and X0. The ratio of 
X0 to total activity did not change on treatment of the 
endothelial cells with PM4 alone or neutrophils alone for 
30 min. In contrast, when the endothelial cells were ex- 
posed to PMA-activated neutrophils for 30 min, the con- 
version of XD to X0 in the cells was enhanced and the 
ratio of X0 to total activity increased to about 32%. The 
time-dependent change in the conversion of XD to X0 is 
shown in Fig. 2. The experiment (n = 4) was repeated 3 
times under the same conditions, and similar result was 
obtained each time. The maximum conversion was ob- 
served at 15 min and this value was maintained for up to 
60 min after the treatment of endothelial cells with PMA- 
activated neutrophils. In the previous paper, we reported 
that the amount of oxygen species produced by PMA- 
activated neutrophils is extremely higher those by other 
stimulant-activated neutrolphils [19]. Therefore, in order to 
determine whether or not the conversion of XD to X0 in 
endothelial cells is specific for the exposure to PMA- 
activated neutrophils, we next examined the effects of 
leukotriene B, (LTB,) and thrombin-activated neutrophils 
on the conversion of XD to X0 in the endothelial cells. 
Endothelial cell monolayers were treated with neutrophils 
(4.7 . lo6 cells/well) and LTB, (final concentration, 1 
PM) or thrombin (1 U/ml). When the endothelial cells 
were exposed to LTB, or thrombin alone, the conversion 
of XD to X0 was not observed. In contrast, the conversion 
of XD to X0 in the endothelial cells was significantly 
stimulated by exposure to neutrophils activated by LTB, 
or thrombin, respectively ((Fig. 3). The experiment (n = 4) 
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Fig. 2. Time course of PMA-activated neutrophil-induced conversion of 
XD to X0. Neutrophils and PMA (open circles) were added at time 0, 
and at the indicated times designated wells were harvested to assay XD 
and X0 activities. X0 activity is expressed as a percentage of the total 
XD and X0 activity. Open squares are representative of HBSS alone. All 
data are presented as mean f S.E., with n = 4. All data are representative 
of 3 times of individual experiments. ?? * P < 0.01: significant difference 
from time 0. 
was repeated 3 times under the same conditions, and 
similar results were obtained each time. 
3.2. Involvement of proteases released from activated neu- 
trophils in the conversion of XD to X0 in endothelial cells 
To determine whether or not proteases released from 
activated neutrophils are involved in the conversion of XD 
a 80 
CONT Thrum LTB4 Throm LTB4 PMA 
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Fig. 3. Conversion of XD to X0 induced by thrombin- or LTB,-activated 
neutrophils. HBSS alone or together with neutrophils (4.7. lo6 cells/well) 
was added to endothelial cells, followed by treatment with thrombin (final 
concentration, 1 U/ml), LTB, (final concentration, 1 PM) or phorbol 
12-myristate 13-acetate (PMA, final concentration, 10 ng/ml). After 30 
min, the cells were harvested, and assayed for the contents of XD and 
X0, as described under Section 2. X0 activity is expressed as a percent- 
age of the total XD and X0 activity. All data are presented as mean f SE., 
with n = 4. All data are representative of 3 times of individual experi- 
ments. CONT: no addition, Throm: addition of thrombin, LTB,: addition 
of LTB,, Throm + PMN: addition of thrombin-activated neutrophils, 
LTB, + PMN: addition of LTB,-activated neutrophils. * * P < 0.01: sig- 
nificant difference from CONT. 
106 Y. Wakabayashi et al. /Biochimica et Biophysics Acta 1265 (1995) 103-109 
to X0, various protease inhibitors and an elastase specific 
inhibitor were added to this system. Neutrophils were 
pretreated with inhibitors such as gabexate mesylate (10m7 
M), urinastatin (1000 U/ml), and aprotinin (100 U/ml) 
for 15 min, and then they were added to the endothelial 
cells and activated by PMA. Treatment with these protease 
inhibitors did not affect the production of oxygen species 
by the activated neutrophils (data not shown), and also did 
not suppress the conversion of XD to X0 at all (Fig. 4A). 
The experiment (n = 4) was repeated 2 times under the 
same conditions, and similar results were obtained each 
time. As shown in Fig. 4B, ONO-5046, a specific inhibitor 
of neutrophil elastase, was also not effective as to the 
conversion at any concentration used here (Ki = 0.2 PM 
for neutrophil elastase [20]). Moreover, these inhibitors 
had no significant effect on the adherence of neutrophils to 
endothelial cells (data not shown). The experiment (n = 4) 
was repeated 2 times under the same conditions, and 
similar results were obtained each time. 
Next, we examined the effect of human neutrophil 
elastase on the conversion of XD to X0 in endothelial 
cells (Table 1). As expected, the treatment of endothelial 
cells with human neutrophil elastase did not affect the 
conversion of XD to X0 at all, and the simultaneous 
treatment of endothelial cells with elastase and hydrogen 
peroxide also failed to affect the conversion. The experi- 
ment (n = 4) was repeated 2 times under the same condi- 
tions, and similar results were obtained each time. 
Table 1 
Effects of elastase and hydrogen peroxide on xanthine dehydrogenase to 
xanthine oxidase conversion in endothelial cells 
Treatment X0% + 
None 
1 pg/ml elastase 
1 pg/ml elastase + 10 PM 
hydrogen peroxide 
22.2 + 1.0 
21.9kO.7 
22.4 + 0.5 
Endothelial cell monolayers were treated as indicated for 30 min. Cell 
extracts were then prepared as described under Section 2. All values are 
mean + S.E. (n = 4). All data are representative of hvo separate experi- 
ments. 
’ Xanthine oxidase activity (X0%) as a percentage of that of xanthine 
oxidase plus xanthine dehydrogenase. 
3.3. Involvement of adhesion molecules in the conversion 
of XD to X0 in endothelial cells 
Previous studies indicated that the adhesion of activated 
neutrophils to endothelial cells via CDll/CD18-ICAM- 
is involved in cell injury [12]. This suggests that the 
conversion of XD to X0 in endothelial cells must be 
affected by the adhesion of neutrophils to endothelial cells 
via CDll/CD18-ICAM-1. Neutrophils were pretreated 
with monoclonal antibodies against CDlla or CD18 for 30 
mitt, and then they were added to endothelial cells and 
activated with PMA. The addition of each antibody to this 
system significantly decreased the conversion of XD to 
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Fig. 4. Effects of protease inhibitors on the conversion of XD to X0 induced by Pm-activated neutrophils. Neutrophils were incubated with protease 
inhibitors (A), such as aprotinin (final concentration, 100 U/ml), gabexate mesylate (final concentration, lo-’ M), or urinastatin (final concentration, 
1000 U/ml), or the human leukocyte elastase specific inhibitor (B), ON0 - 5046 (final concentration, 10m3 M to lo-’ MI, for 15 min, and then added 
with PMA (final concentration, 10 ng/ml) to endothelial cell monolayers. After 30 min, the cells were harvested, and assayed for the contents of XD and 
X0, as described under Section 2. X0 activity is expressed as a percentage of the total XD and X0 activity. All data are presented as mean + S.E., with 
n = 4. All data are representative of 2 times of individual experiments. CONT: no addition, NONE: addition of PMA-activated neutrophils, AP: addition of 
aprotinin with PIvIA-activated neutrophils, GM: addition of gabexate mesylate with PMA-activated neutrophils, UR: addition of urinastatin with 
PMA-activated neutrophils. * * P < 0.01: significant ,difference from CONT. 
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Fig. 5. The role of adhesion molecules in xanthine dehydrc___ enase to 
xanthine oxidase conversion. Neutrophils were incubated with mono- 
clonal antibodies against CDlla and CD18 or control IgG for 30 min, 
and then added with PMA (final; concentration, 10 ng/ml) to endothelial 
cell monolayers. After 30 min, Ithe cells were harvested, and assayed for 
the contents of XD and X0 as described under Section 2. X0 activity is 
expressed as a percentage of the total XD and X0 activity, and then 
normalized as a percentage of the CONT untreated mean value. All data 
are presented as mean + SE., wi.th n = 4. All data are representative of 3 
times of individual experiments, COIW no addition, NONE: addition of 
PMA-activated neutrophils, antiCDlla: addition of anti-CDlla antibody 
with PMA-activated neutrophils, anti-CD18: addition of anti-CD18 anti- 
body with PMA-activated neutrophils, IgG: addition of control IgG with 
PMA-activated neutrophils. * ” P < 0.01: significant difference from 
CONT. ## P < 0.01, # P < O.Ofi: significant difference from NONE. 
CON-l NONE STAURO HERE 
+?MN+PMA 
Fig. 6. Effects of tyrosine kina!se inhibitors on the conversion of XD to 
X0 induced by PMA-activated neutrophils. A bovine endothelial cell 
monolayer was incubated with staurosporin or herbimysin for 2 h. After 
washing, neutrophils and PMA (final concentration, 10 ng/ml) were 
added. After 30 min, the cells were harvested, and assayed for the 
contents of XD and X0, as described under Section 2. X0 activity is 
expressed as a percentage of the total XD and X0 activity, and then 
normalized as a percentage of the CONT untreated mean value. All data 
are presented as mean+ S.E., with n = 4. All data are representative of 3 
times of individual experiments. CONT: no addition, NONE: addition of 
PMA-activated neutrophils, SRAURO: endothelial cells pretreated with 
staurosporin, followed by the addition of PMA-activated neutrophils, 
HERB: endothelial cells pretreated with herbimysine and then addition of 
PMA-activated neutrophils, * * P < 0.01: significant difference from 
CONT. Ye P < 0.01: significant difference from NONE. 
X0 in the endothelial cells. Mouse IgG (10 pg/ml) had 
no inhibitory effect on the conversion at all (Fig. 5). The 
experiment (n = 4) was repeated 3 times under the same 
conditions, and similar results were obtained each time. 
3.4. Effects of tyrosine kinase inhibitors on the conversion 
of XD to X0 
It is accepted that the phosphorylation of tyrosine is 
involved in signal transduction after adhesion via specific 
adhesion molecules. Therefore, we next examined the ef- 
fects of tyrosine kinase inhibitors on the conversion of XD 
to X0 induced by PMA-activated neutrophils. Endothelial 
cells were pretreated with herbimysine (final concentra- 
tion, 0.05~) and staurosporin (final concentration, 0.1 PM), 
inhibitors of tyrosine kinase, for 2 h at 37°C. While 
pretreatment with herbimysine or staurosporin did not 
affect the basal level of X0 in the endothelial cells, these 
tyrosine kinase inhibitors inhibited the conversion of XD 
to X0 induced by PMA-activated neutrophils (% inhibi- 
tion of staurosporin = 51.3 k 1.7%, % inhibition of her- 
bimysine = 42.5 k 1.2%) (Fig. 6). The experiment (n = 4) 
was repeated 2 times under the same conditions, and 
similar results were obtained each time. 
4. Discussion 
We previously demonstrated that both hydrogen perox- 
ide released from activated neutrophils and 0; produced 
by X0 in endothelial cells are involved in endothelial cell 
injury elicited by PMA-activated neutrophils [13]. Recent 
studies have also indicated that the treatment of endothelial 
cells with antioxidant enzymes or compounds inhibiting 
X0 activities decreased cell damage [6,7,21,22]. In this 
paper, we demonstrated the effect of activated neutrophils 
on the conversion of XD to X0 in endothelial cells. The 
basal level of X0 comprised about 12% of the sum of the 
XD and X0 activity in the bovine endothelial cells used in 
this study. When PMA-activated neutrophils were added to 
the endothelial cells, the conversion of XD to X0 in the 
cells was stimulated and as a result the X0 activity 
increased. The stimulation of the conversion of XD to X0 
was not observed on the treatment of endothelial cells with 
either PMA alone or neutrophils alone (Fig. 1) The conver- 
sion occurred within 15 min (Fig. 2). Furthermore, the 
conversion of XD to X0 could also be observed when 
neutrophils activated by either LTB, or thrombin were 
added to the endothelial cells (Fig. 3). Activated neu- 
trophils generated and secreted active oxygen species, such 
as superoxide anion (0,) hydrogen peroxide and 
hypochlorous acid (HOCl), and some proteases, such as 
elastase, cathepsin etc. Recent studies have also indicated 
that hydrogen peroxide and elastase secreted by activated- 
neutrophils play some important roles in the endothelial 
cell injury induced by activated-neutrophils [7,13,23]. By 
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means of purified XD Stark et al. [24] have demonstrated 
that protease mediated directly the conversion of the puri- 
fied XD to X0 in vitro. Therefore, we next examined the 
possibility that hydrogen peroxide and elastase caused the 
damage to cell membrane so that elastase could pass 
through the cell membrane and get into the cell to mediate 
conversion of XD to X0 by direct proteolysis. However, 
neither hydrogen peroxide nor human neutrophil elastase 
added exogenously stimulated the conversion of XD to X0 
in endothelial cells (Table 1). The addition of protease 
(trypsin, chymotrypsin, and cathepsin) inhibitors such as 
gabexate mesylate, urinastatin, and aprotinin, and an elas- 
tase inhibitor such as ONO-5046 [20] did not abolish the 
stimulation of the conversion of XD to X0 induced by 
PMA-activated neutrophils (Fig. 4). These data suggest 
that hydrogen peroxide and proteases secreted by activated 
neutrophils are not candidates causing the conversion of 
XD to X0. In contrast, Phan et al. reported that the 
conversion of XD to X0 in rat pulmonary artery endothe- 
lial cells was mediated by elastase released from activated 
neutrophils [25]. They also demonstrated that the conver- 
sion of XD to X0 induced by 100 pg/ml of neutrophil 
elastase was almost the same as that induced by PMA- 
activated neutrophils. In our experiments, hydrogen perox- 
ide was added at 10 ,uM, because the concentration of 
hydrogen peroxide produced by lo6 neutrophils activated 
by PMA (10 ng/ml) was approx. 10 PM [13]. Human 
neutrophil elastase was added at 1 pg/ml, because the 
addition of over 1 pg/ml of the elastase caused a severe 
shape change of the endothelial cells (data not shown). In 
contrast, neutrophils activated by PMA, thrombin or LTB, 
did not cause a shape change of the endothelial cells. 
Therefore, the different data may be due to the different 
species of endothelial cells examined or an indirect effect 
of exogenous elastase. 
Next, we examined whether or not the adhesion of 
activated neutrophils to the endothelial cells causes the 
conversion of XD to X0 in endothelial cells. In the 
previous study, we demonstrated that the adhesion of 
activated neutrophils to endothelial cells via 
CDlla/CD18-ICAM- causes an early increase in the 
intracellular peroxide level [13]. Therefore, in this study 
we examined the involvement of adhesion via 
CDlla/CD18 (LFA-1) and its ligands in the conversion 
of XD to X0 in endothelial cells. When these antibodies 
against CDlla and CD18 were added to coculture systems 
of endothelial cells and PMA-activated neutrophils, the 
conversion of XD to X0 was significantly inhibited, re- 
spectively. In contrast, mouse IgG (10 pg/ml) had no 
inhibitory effect on the conversion. In the previous paper, 
we also demonstrated that these antibodies against 
CDll/CD18 have no effect on the number of neutrophils 
adhered to endothelial cells [12]. These data suggest that 
the adhesion via CDlla/CD18 and its ligands causes the 
conversion of XD to X0, and that this is involved in the 
early increase in the level of intracellular peroxide. Recent 
studies revealed that LFA-1 has at least three ligands, 
ICAM- [lo], ICAM- 1261, and ICAM- [27]. ICAM- 
and ICAM- are expressed on endothelial cells [28,29], 
and ICAM- is associated with the actin-containing cyto- 
skeleton 1301. Durieu-Trautmann et al. reported that the 
adhesion via ICAM- in endothelial cells caused tyrosine 
phosphorylation of the cytoskeleton-associated protein and 
stimulation of p60src tyrosine kinase [31]. Therefore, we 
next examined whether or not tyrosine phosphorylation is 
involved in the conversion of XD to X0 induced by 
activated neutrophils. When endothelial cells were pre- 
treated with tyrosine kinase inhibitors, staurosporin and 
herbimycin, the conversion of XD to X0 induced by 
activated neutrophils was inhibited (Fig. 5). Other intra- 
cellular signal transduction via CDll/CD18-ICAM- re- 
mains unclear, but Huang et al. [32] reported that endothe- 
lial cell calcium increases when neutrophils migrate through 
endothelial cell monolayers. That is, endothelial cell cy- 
tosolic calcium ions increase when neutrophils adhere to 
endothelial cells. The conversion of XD to X0 is known to 
be calcium dependent [33]. These reports suggest the pos- 
sibility that the conversion of XD to X0 may be due to 
increased intracellular calcium ions, which may be caused 
by the adhesion via CDll/CD18-ICAM-1. However, 1,2- 
bis(2-aminophenoxy)ethane-N,N,N”,N’’-tetraacetic acid 
acetoxymethyl ester (BAPTA AM; 50 pM ), an intra- 
cellular Ca2+ chelator [34,35], had no effect on the conver- 
sion of XD to X0 induced by activated neutrophils (the 
ratio of XD to total XD and X0, control (no addition), 
100 f 3.3%; addition of PMA-activated neutrophils, 224.8 
f 9.2%; addition of BAPTA AM with PMA-activated 
neutrophils, 241.0 f 8.5%). These results suggest that the 
conversion of XD to X0 induced by activated neutrophils 
may be dependent on tyrosine kinase, but not on calcium 
ions. A more precise investigation of the mechanism un- 
derlying the involvement of tyrosine phosphorylation in 
the conversion of XD to X0 is in progress in our labora- 
tory. 
References 
[l] Halliwell, B. (1987) FASEB J. 1, 358-364. 
[2] Tate, R.M. and Repine, J.E. (19831 Am. Rev. Respir. Dis. 128, 
552-559. 
[3] Fantone, J.C. and Ward, P.A. (1982) Am. J. Pathol. 107, 397-418. 
[4] Johnson, K.J. and Ward, P.A. (1981) J. Immunol. 126, 2365-2369. 
[5] Bevilacqua, M.P., Pober, J.S., Mendrick, D.L., Cotran, R.S. and 
Gimbrone, M.J. (1987) Proc. Natl. Acad. Sci. USA 84, 9238-9242. 
[6] Varani, J., Fligiel, S.E., Till, G.O., Kunkel, R.G., Ryan, U.S. and 
Ward, P.A. (1985) Lab. Invest. 53, 656-663. 
[7] Weiss, S.J., Young, J., LoBuglio, A.F., Slivka, A. and Nimeh, N.F. 
(1981) J. Clin. Invest. 68, 714-721. 
[8] Peri, G., Chiaffarino, F., Bemasconi, S., Padura, I.M. and Manto- 
vani, A. (1990) J. Immunol. 144, 1444-148. 
[9] Elites, M.J., Osbom, L., Takada, Y., Grouse, C., Luhowskyj, S., 
Hemler, M.E. and Lobb, R.R. (1990) Cell 60, 577-584. 
I’. Wakabayashi et al. /Biochimica et Biophysics Acta 1265 (1995) 103-109 109 
[lo] Marlin, SD. and Springer, T.A. (1987) Cell 51, 813-819. 
[ll] Diamond, MS., Staunton, D.E., Marlin, S.D. and Springer, T.A. 
(1991) Cell 65, 961-971. 
[12] Fujita, H., Morita, I. and Murota, S. (1991) B&hem. Biophys. Res. 
Commun. 177, 664-672. 
[13] Fujita, H., Morita, 1. and Murota, S. (1994) Arch. Biochem. Bio- 
phys. 309, 62-69. 
[14] Ward, P.A. (1991) Am. J. Med. 91, 89-94. 
[15] McCord, J.M. and Fridovich, I. (1968) J. Biol. Chem. 245, 4641- 
4646. 
[16] Parks, D.A. and Granger, D.N. (1986) Acta Physiol. Stand. Suppl. 
548, 87-99. 
[17] Morita, I., Kanayasu, T. and Murota, S. (1984) B&him. Biophys. 
Acta 792, 304-309. 
[18] Terada, L.S., Beehler, C.J., Banejee, A., Brown, J.M., Grosso, 
M.A., Harken, A.H., McCord, J.M. and Repine, J.E. (1988) J. Appl. 
Physiol. 65, 2349-2353. 
[19] Murota, S., Morita, I. and Suds, N. (1990) Ann. N.Y. Acad. Sci. 
598, 182-187. 
[20] Kawabata, K., Suzuki, M.. Sugitani, M., Imaki, K., Toda, M. and 
Miyamoto, T. (1991) Biochem. Biophys. Res. Commun. 177, 814- 
820. 
[21] Martin, W.J. (1984) Am. F:ev. Respir. Dis. 130, 209-213. 
[22] Sacks, T., Moldow, C.F., Craddock, P.R., Bowers, T.K. and Jacob, 
H.A. (1978) J. Clin. Invest. 61, 1161-1167. 
[23] Varani, J., Ginsburg, I., :Schuger, L., Gibbs, D.F. Bromberg, J., 
Johnson, K.J., Ryan, U.S. and Ward, P.A. (1989) Am. J. Pathol. 
135, 435-438. 
[24] Stark, K., Seubert, P., Lynch, G. and Baudry, M. (1989) Biochem. 
Biophys. Res. Commun. 165, 858-864. 
[25] Phan, S.H., Gannon, D.E., Varani, J., Ryan, U.S. and Ward, P.A. 
(1989) Am. J. Pathol. 134, 1201-1211. 
[26] Staunton, D.E., Dustin, M.L. and Springer, T.A. (1989) Nature 339, 
61-64. 
[27] De Fougerolles, A.R. and Springer, T.A. (1992) J. Exp. Med. 175, 
185-190. 
[28] De Fougerolles, A.R., Stacker, S.A., Schwarting, R. and Springer, 
T.A. (1991) J. Exp. Med. 174, 253-267. 
[29] Dustin, M.L., Rothlein, R., Bhan, A.K., Dinarello, CA. and Springer, 
T.A. (1986) J. Immunol. 137, 245-254. 
[30] Carpen, O., Pallai, P., Staunton, D.E. and Springer, T.A. (1992) J. 
Cell. Biol. 118, 1223-1234. 
[31] Durieu-Trautmann, O., Chaverot, N., Cazaubon, S., Strosberg, A.D. 
and Couraud, P.O. (1994) J. Biol. Chem. 269, 12536-12540. 
[32] Huang, A., J., Manning, J.E., Bandak, T.M., Ratau, M.C., Hanser, 
K.R. and Silverstein, S.C. (1993) J. Cell. Biol. 120, 1371-1380. 
[33] Granger, D.N., Hollwarth, M.E. and Parks, D.A. (1986) Acta Phys- 
iol. Stand. 548, 47-63. 
[34] Natarajan, V. and Iwamoto, G.K. (1994) Biochim. Biophys. Acta 
1213, 14-20. 
[35] Waddell, T.K., Fialkow, L., Chan, C.K., Kishimoto, T.K. and 
Downey, G.P. (1994) J. Biol. Chem. 269, 18485-18491. 
